Bioavailability/Bioequivalence on Biopharmaceutical Products

The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed

  • Factors affecting bae
  • BABE studies
  • Assesssment of bioeqivalence
  • In vivo/In vitro studies
  • Latest Updates In BA/BE

Related Conference of Bioavailability/Bioequivalence on Biopharmaceutical Products

August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
August 29-30, 2018 |

International Conference and Exhibition on Drug Safety & Pharmacovigilance

Park Inn By Radisson Toronto Airport West, 175 Derry Road East, Mississauga, ON, L5T 2Z7, Canada
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 14-15 | 2018

13th International Conference on Biosimilars and Biologics

Lisbon | Portugal

Bioavailability/Bioequivalence on Biopharmaceutical Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in